The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© (c) Copyright Thomson Reuters 2016.Drugmakers say Japan R&D spending at risk after government forces price cuts
By Ritsuko Shimizu TOKYO©2024 GPlusMedia Inc.
5 Comments
Login to comment
MarkX
Blackmail, pure and simple. That is what the drug companies are doing. If you lower our prices we won't conduct research in your country. Give us the outlandish prices we are demanding and we will continue to conduct business as usual. How can they with a clear conscience lower the prices is other countries for this new medicine, but keep it high in Japan? Because they know the Japanese gov't will pay! What a bunch of bloodsuckers!
fxgai
Government has no business in setting prices directly. This inevitably leads to supply failures, as we have seen with butter here and virtually everything in Venezuela.
lostrune2
Seems like a fair trade: if price is cut 30%, then R&D spending should also be cut 30%
Who would be spending the same amount when income has fallen? Only governments